John Wilkin
Stock Analyst at Craig-Hallum
(1.28)
# 3,632
Out of 5,182 analysts
6
Total ratings
50%
Success rate
-2.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Buy | $12 → $10 | $3.05 | +227.87% | 2 | Mar 11, 2026 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $14.08 | +6.53% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $33.03 | +36.24% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $6.66 | +20.12% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $5.00 | +480.00% | 1 | Feb 12, 2025 |
Exagen
Mar 11, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $3.05
Upside: +227.87%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $14.08
Upside: +6.53%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $33.03
Upside: +36.24%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $6.66
Upside: +20.12%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $5.00
Upside: +480.00%